Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Leukemia/Lymphoma

Late relapse in patients with diffuse large B-cell lymphoma: Impact of rituximab on their incidence and outcome

British Journal of Haematology | Aug 09, 2019 Leukemia/Lymphoma

Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukemia

Osteoporosis International | Aug 08, 2019 Leukemia/Lymphoma

The incidence, risk factors and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study

Hematological Oncology | Aug 08, 2019 Leukemia/Lymphoma

Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network

Blood Cells, Molecules, and Diseases | Aug 07, 2019 Leukemia/Lymphoma

Ibrutinib–rituximab or chemoimmunotherapy for chronic lymphocytic leukemia

New England Journal of Medicine | Aug 06, 2019 Leukemia/Lymphoma

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

Cancer Medicine | Aug 05, 2019 Leukemia/Lymphoma

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

Journal of the American Academy of Dermatology | Aug 04, 2019 Leukemia/Lymphoma

Association between Bacillus Calmette-Guérin vaccination and lymphoma: A population-based birth cohort study

Journal of Internal Medicine | Aug 04, 2019 Leukemia/Lymphoma

Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia

Cancer | Aug 02, 2019 Leukemia/Lymphoma

Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation–positive acute myeloid leukemia

Cancer | Aug 01, 2019 Leukemia/Lymphoma

« Prev 1 … 30 31 32 33 34 … 81 Next »

Late relapse in patients with diffuse large B-cell lymphoma: Impact of rituximab on their incidence and outcome

Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukemia

The incidence, risk factors and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study

Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network

Ibrutinib–rituximab or chemoimmunotherapy for chronic lymphocytic leukemia

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

Association between Bacillus Calmette-Guérin vaccination and lymphoma: A population-based birth cohort study

Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia

Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation–positive acute myeloid leukemia

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Late relapse in patients with diffuse large B-cell lymphoma: Impact of rituximab on their incidence and outcome

Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukemia

The incidence, risk factors and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study

Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network

Ibrutinib–rituximab or chemoimmunotherapy for chronic lymphocytic leukemia

High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

Association between Bacillus Calmette-Guérin vaccination and lymphoma: A population-based birth cohort study

Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia

Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation–positive acute myeloid leukemia

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic